Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

METTL16 predicts a favorable outcome and primes antitumor immunity in pancreatic ductal adenocarcinoma

9 Sept 2022

Abstract excerpt

Pancreatic carcinogenesis is a complicated and multi-step process. It is substantially assisted by N6-methyladenosine (m6A) RNA modification, especially when mutations of driver genes (KRAS, TP53, CDKN2A, and SMAD4) occur. However, the underlying mechanism remains obscure. In this research, we identified m6A regulators as potential biomarkers when mutations of driver genes occur, and investigated the role of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related gene regulation
Share to Cholangiocarcinoma and Gallbladder Cancer Studies
Share to RNA modifications and cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36158188
DOI: 10.3389/fcell.2022.759020

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

METTL16 predicts a favorable outcome and primes antitumor immunity in pancreatic ductal adenocarcinomaPMID 36158188Read ↗

Role of N6-methyladenosine Regulated lncRNAs in Prognosis, Tumor Microenvironment and Immune Checkpoints of Pancreatic Ductal AdenocarcinomaSemantic proximity Read ↗

Prognostic and immunological analysis of METTL16 in pan-cancerSemantic proximity Read ↗

Molecular characterization and prognostic relevance of m6A regulators in pancreatic adenocarcinomaSemantic proximity Read ↗

N6-Methylandenosine-related lncRNAs as potential biomarkers for predicting prognosis and the immunotherapy response in pancreatic cancerSemantic proximity Read ↗

m1A Regulator ALKBH1 and TRMT10B as Potential Prognostic Biomarkers and Related to Tumor Immune Microenvironment in Pancreatic AdenocarcinomaSemantic proximity Read ↗

m1A Regulator ALKBH1 and TRMT10B as Potential Prognostic Biomarkers and Related to Tumor Immune Microenvironment in Pancreatic AdenocarcinomaSemantic proximity Read ↗

Prognostic Value of m6A RNA Methylation Modulators and Potential Clinical Application in Pancreatic CancerSemantic proximity Read ↗

Prognostic Value of Drug Targets Predicted using Deep Bioinformatic Analysis of M6A-associated lncRNA-based Pancreatic Cancer Model Characteristics and its Tumour MicroenvironmentSemantic proximity Read ↗

m6A Methylation Modification Patterns and Tumor Microenvironment Infiltration Characterization in Pancreatic CancerSemantic proximity Read ↗

N6-Methylandenosine-Related lncRNAs Play an Important Role in the Prognosis and Immune Microenvironment of Pancreatic Ductal AdenocarcinomaSemantic proximity Read ↗

M1A regulator ALKBH1 and TRMT10B as potential prognostic bio markers and related to the tumor immune microenvironment in pan creatic adenocarcinomaSemantic proximity Read ↗

Genetic alterations and functional networks of m6A RNA methylation regulators in pancreatic cancer based on data miningSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.